7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/17/2013

Company Name Symbol %Change
VIASAT INC VSAT
19.35%
OLD SECOND B OSBC
5.76%
GAMCO INVEST GBL
4.61%
CORNING INC GLW
4.47%
SYNCHRONOSS SNCR
4.23%

Assurant Stays Neutral

by Zacks Equity Research

October 12, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

We are reiterating our Neutral recommendation on the shares of Assurant Inc. ( AIZ - Analyst Report ) prior to its third-quarter earnings release, scheduled for October 24, 2012. We expect the company to continue performing favorably during the quarter. However, we are concerned with micro as well as macro economic headwinds faced by its various business lines.

The Zacks Consensus estimates third quarter earnings of $1.35 per share which would translate into earnings growth of 70.5% year over year.
Assurant Solutions has been performing well over the past several quarters. Though results in UK have been disappointing for some quarters, the company has taken several steps to improve in the international arena.
Over the longer time horizon, the international business is anticipated to continue growing at a steadily, and the domestic business should rebound as the economy improves and consumer electronics spending recovers, leading to overall revenue growth.
Though Assurant Health had been underperforming for the past several quarters, its profitability has shown some improvement. In response to the challenging marketplace, the company entered into a network agreement with AETNA signature Administrators and a marketing agreement with American Family. In addition, it focused on the distribution of individual healthy policies to its customers.
The Employee Benefits segment has been pressured by persistent economic challenges in the small group sector leading to higher lapse rates and lower premium growth on in-force policies. Since there have been few new employee additions and a modest wage growth, premium income from the segment will remain under pressure in the near term.
In the absence of a substantial organic growth, Assurant has maintained its bottom-line earnings via an active capital management strategy.
Assurant is conservatively placed with respect to its investment portfolio. It has below-average investment allocations to risky assets such as commercial real estate, European sovereign debt, BBB bonds and subprime/Alt-A securities. We believe this conservative portfolio will cushion earnings if the macro conditions deteriorate.
Based in New York’s financial district, Assurant competes with Principal Financial Group Inc. ( PFG - Analyst Report ) , Loews Corp. ( L - Analyst Report ) and Conesco Inc. ( CNO - Analyst Report ) among others. The company’s stock currently retains a Zacks #3 Rank, which translates into a short-term Hold rating.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.